Jaime Bartushak
Director Financiero/CFO en CITIUS PHARMACEUTICALS, INC. .
Fortuna: 44 239 $ al 30/04/2024
Perfil
Jaime Bartushak is the founder of Leonard-Meron Biosciences, Inc., which was founded in 2013.
He held the title of Chief Financial Officer from 2013 to 2017.
Currently, Mr. Bartushak is the Chief Financial & Business Officer at Citius Pharmaceuticals, Inc. since 2017.
Mr. Bartushak has an educational background, having completed undergraduate and graduate degrees at New Jersey Institute of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/01/2024 | 60 353 ( 0.04% ) | 44 239 $ | 30/04/2024 |
Cargos activos de Jaime Bartushak
| Empresas | Cargo | Inicio |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Director Financiero/CFO | 27/11/2017 |
Antiguos cargos conocidos de Jaime Bartushak.
| Empresas | Cargo | Fin |
|---|---|---|
Leonard-Meron Biosciences, Inc.
 Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leonard-Meron Biosciences, Inc. develops and commercializes critical care products. It offers Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company was founded by Myron Z. Holubiak in October 2013 and is headquartered in Cranford, NJ. | Fundador | 01/11/2017 |
Formación de Jaime Bartushak.
| New Jersey Institute of Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CITIUS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leonard-Meron Biosciences, Inc. develops and commercializes critical care products. It offers Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company was founded by Myron Z. Holubiak in October 2013 and is headquartered in Cranford, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Jaime Bartushak
